This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a York University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension.
The European respiratory journal · 2026
Sotatercept Improves Small Airway Disease and Hyperinflation in Patients with Pulmonary Hypertension.
medRxiv : the preprint server for health sciences · 2025
Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses.
Nature communications · 2024
Latest funding
- $45,865
Act up: From managing LGBTQ2S+ identity to changing workplace discrimination
SSHRC · 2021 · Co-investigator
- $24,905
Do you see what I see? The role of LGBTQ2+ employees' network in shaping their experiences of workplace discrimination and wellbeing
SSHRC · 2021 · Principal investigator
- $124,040
Act up: From managing LGBTQ2S+ identity to changing workplace discrimination
SSHRC · 2021 · Co-investigator
15 publications.
Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension.
Poor HD, Zhang J, Hannah-Clark S, Saini S, Eisenberg E, Wang J, Lee AG, Serrao G, Schotland H, Rogers L, Smith BM, Beasley MB, Li M, Powell CA, Ventetuolo CE, Padilla M
Sotatercept Improves Small Airway Disease and Hyperinflation in Patients with Pulmonary Hypertension.
Poor HD, Zhang J, Hannah-Clark S, Saini S, Eisenberg E, Wang J, Lee AG, Serrao G, Schotland H, Rogers L, Smith BM, Beasley MB, Li M, Powell CA, Ventetuolo CE, Padilla M
Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses.
Douvaras P, Buenaventura DF, Sun B, Lepack A, Baker E, Simpson E, Ebel M, Lallos G, LoSchiavo D, Stitt N, Adams N, McAuliffe C, Forton-Juarez A, Kosmyna B, Pereira E, Burnett B, Dilworth D, Fisher S, Wang J, Tonge P, Tomishima M, Paladini C, Wilkinson D, Soh CL, Srinivas M, Patsch C, Irion S
Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.
Chang A, Xiang X, Wang J, Lee C, Arakhamia T, Simjanoska M, Wang C, Carlomagno Y, Zhang G, Dhingra S, Thierry M, Perneel J, Heeman B, Forgrave LM, DeTure M, DeMarco ML, Cook CN, Rademakers R, Dickson DW, Petrucelli L, Stowell MHB, Mackenzie IRA, Fitzpatrick AWP
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma.
Moore MR, Friesner ID, Rizk EM, Fullerton BT, Mondal M, Trager MH, Mendelson K, Chikeka I, Kurc T, Gupta R, Rohr BR, Robinson EJ, Acs B, Chang R, Kluger H, Taback B, Geskin LJ, Horst B, Gardner K, Niedt G, Celebi JT, Gartrell-Corrado RD, Messina J, Ferringer T, Rimm DL, Saltz J, Wang J, Vanguri R, Saenger YM
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities.
Davis KD, Aghaeepour N, Ahn AH, Angst MS, Borsook D, Brenton A, Burczynski ME, Crean C, Edwards R, Gaudilliere B, Hergenroeder GW, Iadarola MJ, Iyengar S, Jiang Y, Kong JT, Mackey S, Saab CY, Sang CN, Scholz J, Segerdahl M, Tracey I, Veasley C, Wang J, Wager TD, Wasan AD, Pelleymounter MA
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death.
Kulkarni PM, Robinson EJ, Sarin Pradhan J, Gartrell-Corrado RD, Rohr BR, Trager MH, Geskin LJ, Kluger HM, Wong PF, Acs B, Rizk EM, Yang C, Mondal M, Moore MR, Osman I, Phelps R, Horst BA, Chen ZS, Ferringer T, Rimm DL, Wang J, Saenger YM
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, Lee JL, Vasiliev A, Miller WH, Gurney H, Schmidinger M, Larkin J, Atkins MB, Bedke J, Alekseev B, Wang J, Mariani M, Robbins PB, Chudnovsky A, Fowst C, Hariharan S, Huang B, di Pietro A, Choueiri TK
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M, ASTRAL-2 Investigators, ASTRAL-3 Investigators
Identification of bacterial sRNA regulatory targets using ribosome profiling.
Wang J, Rennie W, Liu C, Carmack CS, Prévost K, Caron MP, Massé E, Ding Y, Wade JT
Act up: From managing LGBTQ2S+ identity to changing workplace discrimination
Principal investigators: Chuang, You-Ta
Keywords: LGBTQ2s+; workplace discrimination
Do you see what I see? The role of LGBTQ2+ employees' network in shaping their experiences of workplace discrimination and wellbeing
Principal investigators: Wang, Jing
Keywords: LGBTQ2+; discrimination; workplace; network; support; wellbeing
Act up: From managing LGBTQ2S+ identity to changing workplace discrimination
Principal investigators: Chuang, You-Ta
Keywords: LGBTQ2s+; workplace discrimination
LGBT employees' work experiences in Canada: A comparison with heterosexual counterparts
Principal investigators: Wang, Jing
Keywords: sexual minorities; discrimination; social support; intrahousehold specialization; job satisfaction; commitment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Curtis Cooper and Jing Wang: 1 shared paper
- Curtis Cooper and Jing Wang: 1 shared paper
- Jing Wang and Jing Wang: 1 shared paper
- Industrial Relations
- Department of Medicine
- Cellular and Molecular Medicine
Co-authors at York University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.